Detalhe da pesquisa
1.
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.
Blood
; 139(18): 2747-2757, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511184
2.
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
Am J Hematol
; 98(2): 264-271, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588407
3.
Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.
Acta Haematol
; 142(4): 197-207, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31163431
4.
Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey.
Eur J Haematol
; 100(4): 361-366, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29285836
5.
Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
Haematologica
; 102(9): 1594-1604, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596280
6.
Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.
Mol Med
; 21: 123-33, 2015 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25584781
7.
COVID-19, impact on myeloma patients.
Ann Hematol
; 99(8): 1947-1949, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577846
8.
AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.
Haematologica
; 97(4): 608-15, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058221
9.
Recommendations on the management of multiple myeloma in 2020.
Acta Clin Belg
; 77(2): 445-461, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355041
10.
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study.
Clin Hematol Int
; 4(4): 133-143, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227519
11.
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.
Blood
; 113(22): 5401-11, 2009 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19349618
12.
Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.
Ann Hematol
; 90(6): 655-66, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21318574
13.
Diabetes insipidus and acute myeloid leukemia harboring monosomy 7: report of two cases and literature review.
Acta Clin Belg
; 76(2): 132-135, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31452466
14.
An unusual progressive stridor.
Breathe (Sheff)
; 16(2): 200006, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33304399
15.
Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study.
Ann Hematol
; 87(11): 881-5, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18641985
16.
The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.
Clin Cancer Res
; 24(20): 5048-5057, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945996
17.
Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.
Clin Epigenetics
; 8: 132, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27980696
18.
Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control.
PLoS One
; 10(5): e0127209, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25978814
19.
Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
Epigenetics
; 9(10): 1374-81, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25437053
20.
Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.
Leuk Res
; 38(5): 557-63, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24661630